HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julien Viaud Selected Research

Julien Viaud Research Topics

Disease

7Neoplasms (Cancer)
11/2019 - 09/2009
4Thrombosis (Thrombus)
11/2020 - 11/2017
2Congenital Structural Myopathies (Centronuclear Myopathy)
01/2022 - 12/2014
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2019 - 06/2013
1Hemorrhage
11/2019
1Proteostasis Deficiencies
01/2018
1Neuromuscular Diseases (Neuromuscular Disease)
01/2018
1Pathologic Processes
01/2018
1Communicable Diseases (Infectious Diseases)
06/2016
1Obesity
03/2016
1Inborn Genetic Diseases (Disease, Hereditary)
11/2015
1Lymphoma (Lymphomas)
06/2014
1Bacterial Infections (Bacterial Infection)
06/2014
1Drug-Related Side Effects and Adverse Reactions
09/2009

Drug/Important Bio-Agent (IBA)

6Phosphotransferases (Kinase)IBA
11/2020 - 09/2009
6Phosphatidylinositols (Phosphatidylinositol)IBA
11/2020 - 11/2010
5LipidsIBA
11/2020 - 06/2014
2EnzymesIBA
06/2016 - 11/2015
2Proteins (Proteins, Gene)FDA Link
12/2014 - 06/2013
1Valproic Acid (Depakote)FDA LinkGeneric
01/2022
1ibrutinibIBA
11/2019
1acalabrutinibIBA
11/2019
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2019
1Cytoskeletal ProteinsIBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1phosphatidylinositol 3,4,5-triphosphateIBA
01/2018
1SAR405IBA
11/2017
11- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA
11/2017
1Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA
12/2014
1Dynamins (Dynamin)IBA
12/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2014
1Anaplastic Lymphoma KinaseIBA
06/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2014
1phosphatidylinositol 5-phosphateIBA
06/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2010
1Adenosine Triphosphate (ATP)IBA
09/2009

Therapy/Procedure

3Therapeutics
01/2022 - 11/2019